The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Launched by ·

Keywords

ClinConnect Summary

This clinical trial is studying whether a helpful type of bacteria called Clostridium butyricum can reduce side effects in people receiving extra chemotherapy treatment after surgery for colorectal cancer, which is cancer in the colon or rectum. Chemotherapy can sometimes cause uncomfortable or harmful effects, and this study wants to see if taking this bacteria as a supplement can make treatment easier and safer.

The trial is open to adults of all genders who have colorectal cancer and are starting additional chemotherapy after surgery. While the study isn’t recruiting yet, eligible participants will be asked to take Clostridium butyricum during their chemotherapy and will be closely monitored for any side effects. This study is important because it may help improve the quality of life for people undergoing cancer treatment by reducing unwanted symptoms.

Gender

ALL

Eligibility criteria